Literature DB >> 30776588

Inclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity.

Stephen Chu-Sung Hu1, Yi-Chien Lai2, Chi-Ling Lin3, Wen-Sheng Tzeng4, Feng-Lin Yen5.   

Abstract

BACKGROUND: Saikosaponin-d (SSD) is a triterpene saponin isolated from Bupleurum plants. It has been shown to exhibit antioxidant, anti-inflammatory, and anticancer activities. However, its biomedical applications are limited by its poor water solubility. Cyclodextrins are highly water soluble oligosaccharide compounds which can form inclusion complexes with lipophilic drugs.
PURPOSE: We complexed SSD with hydroxypropyl-β-cyclodextrin (HPBCD) in various ratios to form SSD-HPBCD inclusion complexes. The inclusion complexes were evaluated for their solubility, physicochemical properties and cytotoxic effects in cutaneous squamous cell carcinoma cells.
METHODS: Surface morphology of pure SSD and SSD-HPBCD inclusion complexes was evaluated by scanning electron microscopy. Crystalline structure was determined by X-ray diffractometry. Intermolecular hydrogen bond formation between SSD and HPBCD was investigated by Fourier transform infrared spectroscopy. Human cutaneous squamous cell carcinoma HSC-1 cell viability was determined by the MTS assay, and cell apoptosis by the caspase 3/7 assay. Signal transduction pathways were investigated by Western blotting.
RESULTS: SSD-HPBCD inclusion complexes showed greatly increased water solubility. This was associated with an improvement in physicochemical properties, including transformation of crystalline structure to amorphous form, and formation of hydrogen bonds between SSD and HPBCD. In addition, SSD-HPBCD inclusion complexes induced apoptosis in HSC-1 cells, and this was mediated through activation of MAPK and suppression of Akt-mTOR signaling pathways.
CONCLUSION: SSD-HPBCD inclusion complex shows improvement in water solubility and physicochemical properties, and exhibits anticancer effects against cutaneous squamous cell carcinoma cells. Therefore, it may be a potential drug formulation for the treatment of skin cancer.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Apoptosis; Cutaneous squamous cell carcinoma; Hydroxypropyl-β-cyclodextrin; Saikosaponin-d; Solubility

Mesh:

Substances:

Year:  2018        PMID: 30776588     DOI: 10.1016/j.phymed.2018.11.012

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

1.  Anti-Tumor Efficiency of Perillylalcohol/β-Cyclodextrin Inclusion Complexes in a Sarcoma S180-Induced Mice Model.

Authors:  Allan A Rezende; Rafael S Santos; Luciana N Andrade; Ricardo G Amaral; Matheus M Pereira; Cristiane Bani; Mo Chen; Ronny Priefer; Classius F da Silva; Ricardo L C de Albuquerque Júnior; Eliana B Souto; Patrícia Severino
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

2.  Enhanced oral bioavailability of koumine by complexation with hydroxypropyl-β-cyclodextrin: preparation, optimization, ex vivo and in vivo characterization.

Authors:  Qing Hu; Xiaoling Fu; Yanping Su; Yanfang Wang; Sihuan Gao; Xiaoqin Wang; Ying Xu; Changxi Yu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 3.  Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics.

Authors:  Piao Zhou; Wei Shi; Xiao-Yan He; Quan-Yu Du; Fei Wang; Jing Guo
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 4.  An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Dan Nicolae Păduraru; Adelina-Gabriela Niculescu; Alexandra Bolocan; Octavian Andronic; Alexandru Mihai Grumezescu; Rodica Bîrlă
Journal:  Pharmaceutics       Date:  2022-08-22       Impact factor: 6.525

Review 5.  Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment.

Authors:  Ka Hong Wong; Aiping Lu; Xiaoyu Chen; Zhijun Yang
Journal:  Molecules       Date:  2020-08-09       Impact factor: 4.411

Review 6.  The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents.

Authors:  Alexandra Prodea; Alexandra Mioc; Christian Banciu; Cristina Trandafirescu; Andreea Milan; Roxana Racoviceanu; Roxana Ghiulai; Marius Mioc; Codruta Soica
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.